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Selector function of MHC I 
molecules is determined by protein 
plasticity
Alistair Bailey1,3,4,*, Neil Dalchau2,*, Rachel Carter1,3, Stephen Emmott2, Andrew Phillips2, 
Jörn M. Werner1,4 & Tim Elliott1,3
The selection of peptides for presentation at the surface of most nucleated cells by major 
histocompatibility complex class I molecules (MHC I) is crucial to the immune response in vertebrates. 
However, the mechanisms of the rapid selection of high affinity peptides by MHC I from amongst 
thousands of mostly low affinity peptides are not well understood. We developed computational 
systems models encoding distinct mechanistic hypotheses for two molecules, HLA-B*44:02 (B*4402) 
and HLA-B*44:05 (B*4405), which differ by a single residue yet lie at opposite ends of the spectrum 
in their intrinsic ability to select high affinity peptides. We used in vivo biochemical data to infer 
that a conformational intermediate of MHC I is significant for peptide selection. We used molecular 
dynamics simulations to show that peptide selector function correlates with protein plasticity, and 
confirmed this experimentally by altering the plasticity of MHC I with a single point mutation, which 
altered in vivo selector function in a predictable way. Finally, we investigated the mechanisms by 
which the co-factor tapasin influences MHC I plasticity. We propose that tapasin modulates MHC I 
plasticity by dynamically coupling the peptide binding region and α3 domain of MHC I allosterically, 
resulting in enhanced peptide selector function.
Peptides bound to Major histocompatibility complex class I (MHC I) molecules are displayed at the sur-
face of most nucleated cells in jawed vertebrates for surveillance by cytotoxic T-lymphocytes (CTL)1–3. 
In transformed or diseased cells, peptides derived from viral or aberrantly expressed proteins are pre-
sented alongside peptides derived from native proteins. This is possible because MHC I has degenerate 
specificity: each molecule can bind a range of peptides of different lengths and sequences. In selecting 
peptides and presenting them at the cell surface, MHC I provides CTLs with a sample of the internal cell 
proteome. This property makes MHC I an attractive target for the development of immunotherapies that 
exploit the CTL response. Examples include therapies that modulate the overall cell surface presentation 
of peptides by MHC I, or that target MHC I at the cell surface with specific peptide vaccines to make 
cells more, or less, visible to CTLs.
The selection of peptides by MHC I occurs in the endoplasmic reticulum (ER) and is modulated by 
a multi-protein complex into which the MHC I:β 2m heterodimer is recruited. This peptide loading com-
plex comprises of the peptide Transporter associated with Antigen Presentation (TAP), which transports 
peptides into the ER, chaperone proteins calreticulin and ERp57, and an MHC I-specific cofactor tapasin 
(reviewed in4). Incorporation of MHC I molecules into the peptide loading complex locates them in close 
proximity to the peptide supply. Here, MHC I interacts with cofactor molecules to preferentially select 
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peptides of high affinity from the large intracellular pool of many potential peptides of largely lower 
affinity5,6. Selection of high affinity peptides confers stability and immunogenicity to MHC I7,8 and is one 
of the most important factors in establishing the specificity and intensity of a CTL response9. We refer 
to the peptide selector function of MHC I as its ability to preferentially select higher affinity peptides over 
lower affinity ones. This in turn profoundly influences the downstream MHC I function of presenting 
peptides to CTLs.
MHC I molecules are highly polymorphic, but have a common tertiary structure (Fig. 1) consisting 
of: the polymorphic heavy chain, monomorphic β 2-microglobulin (β 2m), and a peptide of generally 
8–10 amino acids in length, non-covalently bound into a peptide binding groove. Intrinsic differences 
in the peptide selector function of different allelic variants of MHC I molecules become most appar-
ent when the co-factor molecule tapasin is non-functional or absent. This is because tapasin masks 
these intrinsic differences by preferentially enhancing the selector function of MHC I molecules that 
are inefficient at selecting high affinity peptides10,11. When tapasin is absent, differences in the primary 
sequence of MHC I are sufficient to alter peptide selector function12. For example, two human alleles 
HLA-B*35:01 and HLA-B*52:01 differ by 12 residues in their primary sequence. In the absence of tapa-
sin, HLA-B*35:01 molecules are expressed at a high level at the cell surface, whilst HLA-B*52:01 mol-
ecules are only observed at low levels13. Remarkably, even a single amino acid difference can alter the 
intrinsic peptide selector function of MHC I: HLA-B*44:02 (B*4402) and HLA-B*44:05 (B*4405) differ 
by a single residue at position 116 (Fig. 1A), yet they lie at opposite ends of the spectrum in their intrinsic 
ability to select high affinity peptides in the absence tapasin10–14. In tapasin-deficient cells, B*4402 is poor 
at sampling the peptidome and as a consequence is degraded in the endoplasmic reticulum (ER), while 
B*4405 is able to effectively select high affinity peptides and present them at the cell surface.
These observations of allelic differences in intrinsic MHC I peptide selector function imply that 
tapasin normalizes the peptide selector function of MHC I alleles. However, a mechanistic explanation 
for how tapasin achieves this is lacking. Furthermore, despite there being many crystal structures of 
MHC I, the structural basis for intrinsic differences in selector function between MHC I alleles remains 
unknown. Importantly, what is not revealed by X-ray crystallography is the formation of a MHC I pep-
tide complex and the significance or otherwise of the processes involved. For example, the structures of 
B*4402 and B*4405 reveal highly similar peptide bound conformations with a RMSD of 0.3 Å between 
their secondary structures15,16 (Fig. 1B), and are therefore unable to provide insight into the known func-
tional differences in peptide selection. However, the simple observation that the peptide is buried deep 
in the peptide binding groove of MHC I (Fig. 1C) suggests that MHC I is likely to explore intermediate 
conformational states during the formation of a stable complex, simply to allow peptides to enter and 
leave the groove. In other words, this observation alone suggests that MHC I molecules must be plastic 
in order to sample and bind a range of peptides. Different methods have provided indirect evidence that 
peptide binding to MHC I is associated with a conformational intermediate17–21, including molecular 
dynamics simulations22–25. Although these studies have helped to resolve the apparent paradox of how 
MHC I molecules of such degenerate specificity can bind peptides with such high affinity, they do not 
provide a framework for understanding the mechanism of peptide selection inside cells.
Figure 1. Structure of the MHC I molecule (A) Ribbon representation of the MHC I molecule HLA-
B*44:05 and its three components: a polymorphic heavy chain (yellow), non-covalently bound invariant β2m 
(yellow) and peptide (red). The polymorphic residue 116 between B*4402 and B*4405 is shown in blue (B) 
Comparison of B*4402 (PDB: 1M6O, green) and B*4405 (PDB: 1SYV, blue) structures. RMSD between them 
of 0.3 Å. (C) Combined ribbon and surface representation of the MHC I molecule peptide binding groove.
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Our aim therefore was to further elucidate the relationship between MHC I structure and MHC I 
function in the context of the complexity of the cellular environment. We sought to address this challenge 
for the MHC I presentation system, by adopting an interdisciplinary approach to infer mechanism from 
in vivo biochemical experiments. We use computational systems models that test several mechanistic 
hypotheses of MHC I peptide selection, and quantify the uncertainty in each model. This provides us 
with a rigorous mathematical basis for comparing competing mechanistic hypotheses, and for identifying 
which hypothesis best explains the experimental data. As becomes apparent below, in the case of antigen 
processing this centers on the plasticity of MHC I. We then relate observations at the cellular level to 
protein structure and function using molecular dynamics simulations of MHC I. As has been noted, 
combining three disciplines presents challenges to the reader in interpreting the results and assessing 
their validity26. However, this approach yields information about mechanism that only becomes apparent 
when considering all three disciplines in combination. Specifically, we test the hypothesis that confor-
mational intermediates of MHC I molecules are directly relevant for the peptide selector function of 
MHC I. This work represent a first step towards establishing a general framework for inferring molecular 
mechanism from complex biological data in the context of MHC I peptide selection, with its subsequent 
importance for modulating the immune response.
Results
An enhanced intrinsic selector function for B*4405 over B*4402. To investigate the mechanisms 
of peptide selection by MHC I, we first quantified peptide selector function in vivo for two functionally 
distinct MHC I molecules, B*4402 and B*4405. We then developed computational systems models of 
MHC I peptide selection as sets of biochemical reactions to encode distinct mechanistic hypotheses, and 
used Bayesian model selection to determine which hypotheses were most likely, given the experimental 
data.
To quantify peptide selector function in vivo, we measured the fraction of a pulse-labelled cohort 
of MHC I molecules that were stable at 50 °C, 37 °C and 4 °C as they progressed through the secretory 
pathway over 120 minutes (Fig. 2A,B, quantified in F,G). Since the thermal stability of MHC I has been 
shown to act as a surrogate for the affinity of peptide bound to MHC I10, this allows the quantification 
of the selection of high affinity peptides by MHC I. Figure 2A shows that, as demonstrated previously10, 
in tapasin-deficient cells B*4405 is able to select high affinity peptides. This is indicated by the relative 
proportions of thermostable MHC I complexes harvested from the cells at each time point.
Over time, B*4405 (Fig.  2A, quantified in F) has a larger proportion of complexes stable at higher 
temperatures. However, B*4402, with a lower proportion of stable complexes was therefore less able to 
select high affinity peptides. Furthermore, in the absence of tapasin, B*4402 is mostly sensitive to the 
enzyme Endoglycosidase H which indicates that B*4402 was less able to acquire high affinity peptides 
and progress to the cell surface (Fig. 2B, quantified in G).
A conformational intermediate of MHC I is significant for peptide selector function. To 
investigate the mechanisms of MHC I peptide selection, we developed computational systems models 
of the antigen processing pathway as sets of biochemical reactions that encoded distinct mechanistic 
hypotheses. We defined our models as extensions to a previous computational systems model of MHC 
I assembly, peptide selection and cell surface presentation27. This modelling approach enabled us to 
observe the effects of individually or simultaneously varying all parameters over physiologically relevant 
ranges. It also allowed testing of different mechanistic hypotheses against biological data, thereby pro-
viding a springboard for further experimental investigation. Our previous analysis identified the rate of 
peptide binding to MHC I as the parameter differentiating HLA-B alleles B*4402, B*4405, and B*270527. 
To determine how the rate of peptide binding might be controlled by MHC I itself, in addition to 
factors such as the concentration of peptide in the ER or the volume of the ER, we incorporated 
inherent plasticity of MHC I as a minimal extension to the original model27, by explicitly describing 
two conformational states of MHC I: a peptide-receptive open conformation to which peptides bind 
at rate b, and a non-receptive closed conformation (Fig.  2C,D). We represented MHC I and peptide 
as a system of molecular species that interact with defined reaction rates, including rates of MHC I 
and peptide generation and degradation, and transport from the ER to the cell surface. The reaction 
rates were considered as unknown parameters, and were fitted to the experimental data (as described 
in the Supplementary Information). In these extended models, the release of peptides from MHC I was 
described in two steps: MHC I opening, followed by peptide-unbinding. This gave rise to two variant 
models in which the interactions determined by the biochemical affinity of peptide for MHC I, the 
peptide-dependent step, could arise from one of two processes. One being that the rate of MHC I open-
ing (oi) is peptide-dependent, the other being that the rate of peptide-unbinding from the open MHC 
I conformation (ui) is peptide-dependent. The subscript i indicates the opening or unbinding rate for a 
given peptide i. The descriptor “open” does not have a measured structural correlate, but we assumed that 
the structural correlate of “closed” was the common crystallographic structure of peptide bound MHC I 
complexes. This assumption includes MHC I containing very weakly bound peptides such as those that 
occupy only the F-pocket28.
To determine which mechanistic hypotheses were most likely, we compared model simulations with 
experimental data using Bayesian parameter inference and model selection. To simulate the range of 
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Figure 2. For legend see next page.
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thermostability that was measured, representative peptides with high, medium or low affinities for MHC 
I were used in the model. In Fig.  2F,G, the experimental data from Fig.  2A,B is indicated by circles, 
and the model simulations reproducing the data are indicated by lines. To assess the plausibility of 
each model, we determined the optimal parameter values using probabilistic inference techniques27. 
We examined a variety of hypotheses for allele-specific mechanisms, by enabling specific parameters 
(such as the rate of closing) to take on different values for each allele, while keeping the remaining 
parameters the same for all alleles27. For each hypothesis, we refer to the variable parameter as the allele 
parameter. Conclusions were based on the Bayesian Information Criterion (BIC)29, which minimizes the 
deviation between model simulation and experimental observation, while accounting for the effects of 
having different numbers of free parameters in the different models that were tested. Figure  2E shows 
the BIC statistic (shorter bars indicate statistical improvement) for a range of allele parameters for each 
of the three models, including no allele parameter. Comparing BIC statistics for the one conformational 
model (Fig. 2E, top) indicated that an allele-specific rate of peptide binding to MHC I (b) explains the 
differences in peptide selection between the three alleles better than an allele-specific rate of peptide 
free MHC I degradation (dM). Importantly, we found that both of the two-conformation models outper-
formed the original one-conformation model in their ability to reproduce the experimental data, with 
improved performance sufficient for their additional parameters to be considered justifiable by the BIC 
statistic (Fig. 2E). In other words, this analysis clearly indicates that when testing model hypotheses of 
peptide selection, a two-conformation MHC I model provides a better explanation of the experimental 
observations than a one-conformation model. In particular, the one-conformation model was unable to 
reproduce a key experimental observation of slow conversion of MHC complexes to a mature measur-
able state, which had a maximal signal at 30 minutes post radiolabelling (see Figure S7). Moreover, the 
two-conformation model where the opening rate (oi) of the closed MHC I peptide complex (McPi) was 
peptide-dependent, and the closing rate (c) of open peptide bound MHC I (MoPi) was allele-dependent, 
provided the best description of the data (Fig. 2E, bottom).
Faster closing of MHC I corresponds with enhanced intrinsic selector function. Interestingly, 
for the most likely model determined in Fig. 2E, B*4405 showed a relatively fast closing rate (Fig. 2H, 
bottom) corresponding with faster progression to a stable conformation, consistent with its enhanced 
intrinsic selector function observed experimentally (Fig.  2F, bottom). B*4402 showed a slower closing 
rate (Fig. 2H, top), corresponding with a slower progression to a stable conformation, consistent with a 
diminished intrinsic selector function (Fig. 2F,G, top). Our results therefore suggest that the intrinsic dif-
ferences in selector function between these MHC I alleles arise from intrinsic differences in their ability 
to move from open to closed conformations. The closing rate c corresponds to the rate at which MHC 
I progresses to a stable conformation, from which it is able to exploit the peptide-dependent opening 
step. Specifically, frequent progression to a stable conformation (i.e. fast closing) enables the preferential 
exchange of low affinity peptides (characterized by fast oi) for high affinity peptides (characterized by 
Figure 2. Computational systems models of the mechanisms of MHC I peptide selection, fit to in 
vivo peptide selection data for B*4402 and B*4405 in the absence of tapasin. (A) Time-dependent 
peptide selection measured with pulse-chase and thermostability in tapasin-deficient cells, as described in 
materials and methods. Tapasin deficient cultured 220 cells (721.220) were metabolically radiolabelled with 
35S-met for 5 min, then chased for the indicated times before being lysed and heated to the temperatures 
shown (data quantified in F). (B) Cell surface transit measured as percentage endoglycosidase-H (EndoH) 
resistance. MHC I was immunoprecipitated with W6/32 and treated at the different time points with 
(+ ) or without (− ) EndoH, which distinguishes between sensitive, pre-cis-Golgi (ES) and resistant (ER) 
post-cis-Golgi MHC I (data quantified in G). Immunoprecipitations were performed in such a way as to 
record only MHC I bound to high affinity peptides (10). (C) A general computational systems model of the 
mechanisms of peptide selection in the absence of tapasin. Shapes represent molecular species and labelled 
boxes represent reactions and their rate parameters. (D) Different binding mechanisms are illustrated for 
one-conformation and two-conformation models, where peptide-dependent reactions are indicated by 
thick red symbols. (E) Comparison of model performance for different parameters taking allele-specific 
values (allele parameters). The most likely model (lowest BIC score) was the two-conformation model with 
MHC I opening as the peptide-dependent step and MHC I closing rate c as the allele-dependent parameter. 
(F,G) Comparison of the most likely model (solid lines) against experimental measurements (circles), with 
95% confidence intervals (shaded regions). (F) Quantification of pulse chase experiments shown in panel 
A (circles), together with model simulations (lines). Red indicates the proportion of MHC I molecules that 
remained after heating to 50 °C (high affinity peptide-MHC complexes), green indicates heating to 37 °C 
(medium and high affinity complexes) and blue indicates heating to 4 °C (all complexes). (G) Quantification 
of cell surface transit experiments shown in panel B (circles), together with model simulations (lines). 
(H) Marginal posterior density of the allele-specific closing rate c, reflecting the probability of the parameter 
values, conditional on the measured data and underlying model.
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Figure 3. Quantification of protein plasticity for MHC I alleles B*4402, B*4405 and B*4405W147A from 
molecular dynamics simulations. (A) Left: Surface representation of peptide bound MHC I. Middle: 
Ribbon representations of peptide free MHC I. The polymorphism between B*4402 and B*4405 at position 
116 in the peptide binding groove (brown) and mutation B*4405W147A (blue). F-pocket distances were 
measured between the center of mass of helix residues 135–156 and 69–85 (red). Right: Inter-domain 
distances were measured between peptide binding groove residues 96–100 (red) and α 3 residues 220–227 
(red). (B–G) Contour plots of the joint probability densities for the conformations of MHC I populated 
in each simulated condition, as defined by distances in (A). Black crosses indicate the initial structure 
conformation. Distributions for each individual distance are plotted on the outside of the adjacent axis. 
(H–J) The motion most correlated with the distance fluctuations across the F-pocket as defined in  
(A). Cones indicate the direction and amplitude of motion. The range of inter-domain twisting for each 
molecule is indicated by arrows (as depicted in Figure S5). See also Figures S1–S5.
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slow oi), thus enhancing selector function. Put simply, once an MHC I molecule binds a peptide and 
closes, it is the peptide-dependent opening rate of the MHC I molecule that defines the affinity of the 
peptide-MHC interaction. Therefore, if one MHC I molecule closes faster than another, the faster closing 
MHC I molecule reaches the peptide-dependent part of the selection process more quickly, resulting in 
enhanced peptide selector function due to more rapid sampling of peptides.
Peptide selector function of MHC I correlates with protein plasticity. Following the identifica-
tion of functionally relevant conformations of MHC I, we investigated the extent to which these confor-
mations could be linked to protein plasticity. Specifically, we performed molecular dynamics simulations 
of MHC I alleles B*440216 and B*440515, and quantified their plasticity by computing the range and 
frequency of molecular conformations, as described by the relative motions of their backbone atoms, 
under conditions of thermodynamic equilibrium. We then compared the plasticity of these alleles to their 
corresponding peptide selector function.
We performed molecular dynamics simulations using the GROMACS package30 in the peptide bound 
and peptide free states (see Supplementary Information Table S1 for a summary of the simulations). 
The simulations were designed to capture the dynamic behavior of each MHC I molecule in a manner 
independent of timescale. Specifically, we used 10 ns block averaged root mean squared fluctuations to 
assess that there was adequate configurational sampling during the 420 ns simulations, to be consistent 
with equilibrium behavior (Figure S1).
To quantify the range and frequency of conformations adopted by MHC I molecules, we chose to 
focus on two representative distance measures, the F-pocket distance and the inter-domain distance. The 
F-pocket distance corresponds to the distance between the center of mass of helix residues 135–156 
and helix residues 69–85 (Fig.  3A, middle). This was chosen due to the hinge points created between 
the break in the α 2 helix near residue 156 and the end of the α 2 helix near residue 135, about which 
conformational change may occur23. Thus, the F-pocket distance was indicative of the range of confor-
mations that could be adopted by the peptide binding groove. The inter-domain distance corresponds to 
the distance between peptide binding groove residues 96–100 and α 3 domain residues 220–227 (Fig. 3A, 
right). This was chosen to represent the range of motion that could be exhibited between the heavy 
chain domains. From the molecular dynamics simulations, we quantified the frequency with which the 
MHC I molecules adopted conformations with a given F-pocket and inter-domain distance, represented 
as joint probability distributions (Fig.  3B,C,E,F). These distributions indicate the conformations that 
MHC I could adopt, together with the correlations between peptide binding groove and heavy chain 
conformations.
To characterize how motion of the peptide binding groove relates to overall motion of MHC I, we 
performed Functional Mode Analysis (FMA) (See Supplementary Information and Figure S3 for further 
details)31. In correlating the F-pocket distance to the collective motions of the backbone atoms of the 
molecule, FMA determined a single collective motion most correlated with the distance fluctuations 
across the F-pocket, represented as porcupine plots (Fig. 3H,I). The direction of movement in the plots 
is represented by the orientation of the cones, while the amplitude of movement is represented by both 
the size and color of the cones. In this way, FMA provides a description of the conformational change 
undergone by the whole MHC I molecule corresponding to a conformational change of the peptide 
binding groove.
We then compared the plasticity of MHC I alleles B*4402 and B*4405 (Fig. 3) with their correspond-
ing peptide selector function (Fig. 2). In the peptide bound state (Fig. 3B,C), both molecules displayed 
similar plasticity and populated a single dominant conformation, with a sub-population of conforma-
tions arising from inter-domain motion for both alleles. Since these two alleles differ by only a sin-
gle amino acid and exhibit almost identical crystal structures in their peptide bound state, we sought 
to investigate whether the observed differences in peptide selector function were due to differences in 
protein plasticity in the peptide free state. When we repeated the simulations following removal of the 
peptide, this revealed significant differences in plasticity (Fig. 3E,F). In the absence of peptide, B*4402 
populated a single F-pocket conformation (Fig. 3F). In contrast, B*4405 populated several F-pocket con-
formations (Fig. 3E) and explored greater conformational space overall. In Fig. 3H,I, the direction and 
amplitude of the backbone atoms indicated a twisting motion that correlated with F-pocket opening, 
articulated around the domain linker region. This twisting motion was significantly larger for B*4405 
than for B*4402 (see Figure S5 for more details of the twisting analysis).
Taken together, the molecular conformations and movements of atoms indicated that, in the absence 
of peptide, the F-pocket of B*4402 was less plastic than that of B*4405, exploring a more limited con-
formational space and exhibiting a reduced twisting motion (Fig.  3I; Figure S5). Furthermore, these 
differences in plasticity in the absence of peptide correlated with differences in peptide selector function, 
with the more plastic B*4405 exhibiting significantly greater selector function than the less plastic B*4402 
(Fig. 2F,G). Interestingly, this plasticity also correlated with the rate of conformational change from an 
open to a closed conformation in the computational systems model, given by the closing rate c, with 
B*4405 exhibiting a significantly greater closing rate than B*4402. Therefore, by comparing quantifica-
tions of B*4405 and B*4402 plasticity (Fig. 3) with in vivo measurements of peptide selection (Fig. 2F,G), 
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we identified mechanistic hypotheses linking protein plasticity to peptide selector function, as targets for 
further investigation.
Plasticity of MHC I can predict peptide selector function in vivo. To test our hypotheses exper-
imentally, we performed molecular dynamics simulations of a site-directed mutant of B*4405 in which 
the highly conserved Tryptophan 147 was changed to Alanine (B*4405W147A).The identification of this 
novel mutant was somewhat fortuitous and stemmed from a previous study32 describing the effect of 
33 random single site mutations on the recognition of HLA-A*02:01 by alloreactive T cells. During this 
study, a significant effect of a W147 mutation on MHC I intracellular trafficking was observed, suggest-
ing this site as a potential target for investigation. The B*4405W147A novel mutant revealed an interesting 
phenotype that enabled an investigation into the link between sequence, plasticity and selector function. 
Significantly, in peptide free molecular dynamics simulations, B*4405W147A explored fewer peptide bind-
ing groove conformations than wild-type B*4405 (Fig. 3G), and also showed a corresponding reduction 
in the range of the inter-domain twisting, similar to peptide-free B*4402 dynamics (Fig. 3J; Figure S5). 
Furthermore, B*4405W147A showed mobility of the α 3 domain more like B*4402 than B*4405 (Fig.  3J), 
including a highly dynamic 220–227 α 3 loop. Together, these simulations predict that the intrinsic pep-
tide selector function of B*4405W147A should be qualitatively similar to that of B*4402.
Having tested that B*4405W147A molecules were able to select and bind to peptides normally (Fig. 4A), 
we tested our prediction by performing pulse chase analysis as in Fig.  2 for the B*4405W147A mutant 
(Fig.  4B,C). We found that the W147A mutation of B*4405 profoundly affected the ability of MHC I 
to select stable peptides and present them at the cell surface in the absence of tapasin, as predicted. To 
mechanistically model the selector function of this mutant, we fit the allele parameter c (closing rate), 
using the optimal two-conformation model of Fig. 2. The allele parameter for B*4405W147A fell between 
the parameter values for B*4405 and B*4402 (Fig. 4D), resulting in a peptide selector function close to 
that of B*4402 (compare Fig. 4E,F with 2F,G), as predicted.
Figure 4. Peptide selection of B*4405W147A measured in vivo and compared with simulations of 
computational systems model. (A) Mutant B*4405W147A has similar peptide binding ability to that of B*4402 
and B*4405. This is demonstrated by performing a BFA decay assay with 220. tapasin cell lines expressing 
each allele. Stability of peptide loaded MHC I over time is measured with the conformation specific antibody 
W6/32. (B,C) Pulse-chase thermostability and EndoH assays in the absence of tapasin were carried out for 
B*4405W147A as in Fig. 2A,B, and as described in materials and methods. (D) Combined likelihood score 
against data for all three alleles in absence of tapasin, for different values of the allele parameter c. An optimum 
for B*4405W147A is present between the mean posterior values for the other two alleles, as labelled. The areas 
indicate the 95% confidence intervals for those two parameters. (Middle, Right) simulation values for the 
maximum likelihood value of c. (E,F) Simulation (lines) of the two-conformation (opening) model with allele 
parameter c set to the value in panel (D) that best fits the experimental data (i.e. that optimizes the likelihood 
function). Plotted together with experimental measurements of B*4405W147A (circles). (E) Experiments relate 
time-dependent peptide selection measured with pulse-chase and thermostability in tapasin-deficient cells 
(quantification of panel B). Red symbols/lines indicate heating to 50 °C (corresponding to high affinity peptide-
MHC complexes), green indicates 37 °C (medium and high affinity complexes) and blue indicates 4 °C (all 
complexes). (F) Cell surface transit measured as percentage EndoH resistance (quantification of panel (C)).
www.nature.com/scientificreports/
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Restraint of the tapasin binding site can modulate MHC I protein plasticity. To further inves-
tigate our hypothesis that protein plasticity determines selector function, we sought to identify potential 
mechanisms that could be used by chaperones to regulate protein plasticity. Specifically, we focused on 
the MHC I allele B*4402 and the chaperone molecule tapasin, which has been shown to significantly alter 
peptide selector function. Previous work identified a C-terminus domain residue of tapasin, R333, which 
interacts with a residue of the 220–227 α 3 loop, E222, in docking simulations between HLA-B*08:01 
and tapasin4. Within this region, mutation of position 222 has been shown to abrogate the interaction 
between MHC I and tapasin, leading to loss of function33. Furthermore, polymorphic differences in this 
region of chicken MHC I have been shown to affect peptide selector function when measured in vitro, 
and correlate with changes in protein dynamics34. We therefore chose to focus on the α 3 loop comprising 
residues 220–227 as a means for tapasin to induce changes in MHC I selector function.
Analysis of molecular dynamic simulations (Fig.  3I; Figure S5) revealed a dominant inter-domain 
twisting motion between the peptide binding domain and the α 3 domain. Furthermore, in peptide-free 
simulations of B*4402, only the 220–227 loop in the α 3 domain showed significant motions correlated 
with F-pocket opening (Fig. 3I). For B*4405, highly correlated motions were observed between the pep-
tide binding domain and the α 3 domain (Fig. 3H), suggesting a communication between distant regions 
of MHC I best described as dynamic coupling (as illustrated by the covariance webs in Figure S2)35,36. 
To further investigate this coupling, we simulated peptide free B*4402 with weak restraints on the Cα 
atoms of residues 220–227 in the α 3 domain, which also mimics the interaction of tapasin in this region. 
Figure  5A shows that, under these conditions, the plasticity of the F-pocket of B*4402 was shifted to 
more closely resemble that of peptide free B*4405, consistent with the existence of dynamic coupling of 
the α 3 and peptide binding domains. This effect was a specific property of the 220–227 region, as similar 
restraints applied to other α 3 regions (residues 188–194, 250–257) had no significant effect on F-pocket 
plasticity (Fig. 5B,C).
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Figure 5. Quantification of B*4402 plasticity with restrained residues at the tapasin binding site, 
and measurement of tapasin binding for B*4402, B*4405 and B*4405W147A. (A) Contour plots of the 
joint probability densities for the conformations populated by peptide free B*4402 with restrained α 3 
domain residues 220–227, the location indicated in panel (C). Black crosses indicate the initial structure 
conformation. Distributions for each individual distance are plotted on the outside of the adjacent 
axis. Restraint of these residues increases B*4402 plasticity by modulating the peptide binding groove 
conformation. (B) Contour plots of the joint probability densities for the control simulations, the locations 
are indicated in panel C. Black crosses indicate the initial structure conformation. Distributions for each 
individual distance are plotted on the outside of the adjacent axis. Restraint of control residues has little 
effect on B*4402 plasticity. (C) Sites of the restraints on MHC I corresponding with simulations in panels  
A and B. (D) B*4405W147A exhibits sustained binding to tapasin, like B*4402, whereas B*4405 does not. Cells 
were lysed in digitonin to preserve the peptide loading complex, which was then immunoprecipitated with 
anti-tapasin antibody. Associated transporter associated with antigen processing (TAP) and MHC I (HC) 
were visualized by Western blot using specific antibodies. See also Figures S1-S5.
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Figure 6. Computational systems models of the mechanisms of MHC I peptide selection, fit to in vivo 
peptide selection data for B*4402, B*4405 and B*4405W147A in the presence and absence of tapasin.  
(A) Repeating the thermostability assay shown in Fig. 2A in the presence of tapasin indicates that B*4402 
and B*4405W147A now acquire thermostability equal to that of B*4405 (quantified in G). (B) Repeating 
the pulse chase assay shown in Fig. 2B in the presence of tapasin shows that all alleles select high affinity 
peptides in the presence of tapasin and traffic to the cell surface (quantified in H). (C) Graphical depiction 
of the general computational systems model of the mechanisms of peptide selection in the presence of 
tapasin, as in Fig. 2D. (D) Comparison of model performance for one-conformation and two-conformation 
models, as in Fig. 2E. The most likely model (with the lowest BIC score) was once again identified as the 
two-conformation model with MHC I opening as the peptide-dependent step and MHC I closing rate c  
as the allele-dependent parameter. (E) Flux analysis of the two-conformation model with peptide-dependent 
opening (including tapasin) reveals an anti-clockwise cycle of tapasin mediated peptide editing (the peptide-
specific reactions are shown as thick red symbols, and grey lines indicate unfavorable reactions).  
(F–H) Comparison of model behavior including a function for tapasin, analogous to Fig. 2F,G. Experimental 
measurements (circles) quantified from Figs 2A,B and 4A,B and panels (A,B) in this figure. In H solid black 
are + tapasin and dashed/open are – tapasin.
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To determine whether differences in protein plasticity induced by restraints of the α 3 domain cor-
related with a physical interaction with tapasin, we measured the binding of tapasin to MHC I in vivo 
for the alleles B*4402, B*4405 and B*4405W147A. We performed pull-down experiments to observe 
co-immunoprecipitation of MHC I with anti-tapasin antibodies from lysates of .220-tapasin-B*4405W147A 
compared to B*4402 and B*4405. As shown previously, B*4402 had a sustained interaction with tapasin 
in vivo, but B*4405 did not15. Strikingly, The W147A mutation conferred sustained tapasin binding to 
the B*4405 molecule, to a level observed for B*4402 (Fig. 5D). Therefore, we reasoned that B*4405 was 
able to select high affinity peptides with significantly reduced tapasin interaction because the enhanced 
plasticity of B*4405 results in enhanced selector function. Whereas B*4402 required tapasin interaction 
to select high affinity peptides because the reduced plasticity of B*4402 resulted in reduced selector 
function. By using a restraint to mimic tapasin interaction, we observed B*4402 becoming more plastic. 
This is consistent with the possibility that tapasin binding to MHC I may be regulated by mobility of 
the 220–227 loop. Furthermore, the tapasin binding event may be communicated to the peptide binding 
groove in such a way as to induce plasticity that promotes peptide selection.
Tapasin enhances peptide selector function by catalyzing transitions between conforma-
tional intermediates of MHC I. Finally, we returned to computational systems modelling to infer 
the mechanisms by which tapasin enhances peptide selector function. We first quantified the effects of 
tapasin on peptide selection in vivo, for the three MHC I alleles B*4402, B*4405 and B*4405W147A. As 
in the absence of tapasin, we developed computational systems models of MHC I peptide selection to 
encode distinct mechanistic hypotheses, and used Bayesian model selection to determine which hypoth-
eses were most likely, given the experimental data.
To quantify peptide selector function in the presence of tapasin, we performed thermostability and 
EndoH pulse-chase experiments in tapasin-competent cells (Fig. 6A,B), similar to the experiments per-
formed in tapasin-deficient cells (Fig.  2). In the presence of tapasin, all three alleles progressed to the 
cell surface with the same rapid kinetics (Fig. 6A, quantified in 6G) and loaded rapidly with stabilizing 
peptides (Fig. 6B, quantified in 6H). This was consistent with the hypothesis that tapasin masked intrinsic 
differences in MHC I selector function, as previously identified.
To model potential mechanisms by which tapasin could enhance peptide selection, we introduced 
tapasin into the one-conformation and two-conformation models of Fig.  2, as shown in Fig.  6C (see 
Supplementary Information and Figure S6 for details of the models). Since tapasin has been shown to 
elevate loading of stable peptides in vivo and to enhance peptide dissociation and association in vitro37,38, 
for the one-conformation model we assumed that tapasin enhanced peptide binding to and unbinding 
from MHC I, as previously suggested27. For the two-conformation models, we assumed that tapasin 
enhanced the peptide-dependent step, together with the rates of transition between conformational states.
To determine which mechanistic hypotheses were most likely, we fit the parameters of each model 
to the experimental data, both in the presence (Figs 2A,B and 4B,C) and absence (Fig. 6A,B) of tapasin, 
for all three MHC I alleles simultaneously. As in the absence of tapasin (Fig. 2E), the model of best fit 
was identified as the two-conformation model, with MHC I opening as the peptide-dependent step and 
MHC I closing rate c as the allele-specific parameter (Fig. 6D). Furthermore, as in the absence of tapasin 
(Fig.  4D), the closing rate for B*4405W147A was identified as lying between the values for B*4402 and 
B*4405 (Table S2). Consistent with biochemical data37,38 we observed a close fit of the model to the data 
when tapasin accelerated both the peptide-dependent rate of opening (factor q) and the allele-dependent 
rate of closing (cT > c) of peptide-bound MHC I (Table S2). Therefore, our modelling results suggest 
that tapasin confers enhanced selector function by acting as a catalyst to enhance MHC I plasticity, and 
thus promote peptide exchange.
To understand how specific interactions contribute to the overall behavior of the system, we per-
formed a flux-analysis of the model (Fig. 6E; see Supplementary Information and Figure S6 for details 
of this analysis). Here, each transition in the model was removed systematically (i.e. set to zero), and the 
effect on the deviation of the model from the experimental data quantified using the maximum likeli-
hood score. For example, we set the rate of the transition from TMoPi to TMo to zero, and found only a 
small effect on model behavior, which suggests that this transition does not significantly affect peptide 
selection. This analysis was applied to all transitions and summarized in Fig.  6E, which shows essen-
tial transitions left in black, transitions with minor contributions in grey, and non-essential transitions 
removed. The scheme illustrates some key features of the model: i) open MHC I preferentially binds to 
tapasin rather than peptide, ii) peptide binds preferentially to tapasin-bound MHC I, and iii) tapasin is 
predicted to dissociate preferentially from closed, peptide occupied MHC molecules. This is consistent 
with recent demonstrations that MHC-binding peptides accelerate the dissociation of tapasin from MHC 
I, measured by surface plasmon resonance38.
Discussion
MHC class I antigen processing can be broadly divided into three phases: peptide generation, peptide 
selection and peptide presentation. The efficiency of peptide selection in the MHC class I pathway, as 
well as in the MHC class II pathway39, has great relevance for disease pathogenesis40,41 and therapeutic 
developments42. Hence we sought a mechanism for MHC I peptide selection, by combining modelling 
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and experimental techniques. We highlight three main areas of future investigation. Firstly, here we have 
simplified a complex system and excluded other factors that may potentially influence peptide selection, 
such as other chaperone molecules and the nature of the peptide supply43. Reducing the system makes 
the problem tractable in the first instance, and creates a foundation upon which to build more complex 
systems. Secondly, we note that molecular dynamics simulations in the peptide free state do not have a 
known corresponding crystal structure: all known structures of MHC I are peptide bound. More gener-
ally, our observations from molecular dynamics are dependent upon simulation time and the reliability of 
the force field to reproduce physical behavior. The simulations presented here are of comparable length, 
or longer, than those previously performed for these MHC I molecules22–24. We anticipate that future 
NMR studies will test the validity of these observations, however there already exists direct structural evi-
dence for MHC I populating more than one peptide bound conformation24,44. Thirdly, the differences in 
MHC I plasticity and corresponding selector function have been shown here for three HLA-B molecules, 
and the generality of this observation remains to be explored, in particular by considering additional 
HLA alleles and point mutations. However, there is in vitro and computational evidence suggesting that 
plasticity is a common functional property of MHC I19,20,22,24,45,46 and many other proteins36,47.
In correlating our observations from the computational systems modelling with those from the 
molecular dynamics simulations, we can start to build a framework for understanding the mechanisms 
of MHC I peptide selection. This framework describes how the functional differences in conformational 
intermediates of distinct MHC I alleles can arise from intrinsic differences in the plasticity of the heavy 
chain structure encoded by a single amino acid polymorphism. Moreover, we have been able to dis-
tinguish between the intrinsic selector properties of MHC I molecules and the impact of the cofactor 
tapasin in modulating MHC I peptide selection. Our flux analysis identifies that tapasin binds preferen-
tially to conformational intermediates of MHC I and accelerates the closing rate of MHC I, increasing 
the likelihood of selecting a high affinity peptide. These observations correlate with recent observations 
of the assembly efficiency of different HLA-B alleles in the absence and presence of tapasin13. The corre-
lation with our model is that an MHC I allele with a slow closing rate progresses slowly to the peptide 
dependent step in the absence of tapasin, thus having a retarded selector function. The model assigns the 
function of tapasin as one of a catalyst-chaperone, accelerating the rate of closure of MHC I and thus the 
rate at which MHC I reaches the peptide dependent step. This is consistent with previous investigations 
indicating that peptide selection by MHC I depends upon conformational change48. Our analysis of the 
flux of MHC I through the model revealed an iterative cycle of tapasin catalyzed peptide exchange, which 
continues until a peptide of sufficiently high affinity enables MHC I to egress from the ER. This is not 
dissimilar to the model proposed for HLA-DM and HLA-DR in the MHC Class II pathway49–51. From 
examination of the crystal structure of DR and the DM-DR complex it has been postulated that DM 
modulates the conformation of peptide free DR such that peptides accessing the peptide binding groove 
must compete with DM for DR to reverse the conformational change, triggering DM dissociation. This is 
analogous to tapasin modulated conformational change of MHC I, leading to an increased rate at which 
MHC I reaches the peptide dependent step in our model, in turn enhancing both the rate, and quantity, 
of high affinity peptides selected. A key finding in our model is that the difference in intrinsic peptide 
selection efficiency between alleles can be explained by intrinsic differences in their ability to undergo 
conformational changes. This is striking because B*4405 and B*4402 differ by only a single amino acid.
Previously, it has been shown by molecular dynamics simulation23 that the position 116 polymorphism 
alters the plasticity of B*4405 and B*4402. By extending these observations to include the B*4405W147A 
allele we observed a correlation between plasticity and the rate of transition between an open and closed 
conformation of the peptide binding domain. This suggests a link between plasticity and closing rate 
such that more plastic MHC I alleles are able to close more quickly. Furthermore, by extending our 
observations to include the α 3 domain we can postulate two ways in which plasticity determines pep-
tide selection at a structural level. Firstly, through our observation of coupled dynamics between the 
membrane proximal α 3 domain and peptide binding site of the MHC I heavy chain, we see how the 
116 polymorphism or the W147A mutation can alter the intrinsic plasticity of these molecules. In the 
case of B*4405W147A we observe a shift in plasticity towards that of the B*4402 phenotype. Secondly, 
in demonstrating that we can modulate the conformation of the peptide binding groove of B*4402 via 
the 220–227 region of the α 3 domain, we provide an explanation of how tapasin may catalyze peptide 
selection both directly via the peptide binding site and additionally allosterically: a phenomenon we also 
recently observed in chicken MHC34. It has also been reported that MHC I displays plasticity at the short 
310 helix forming part of the peptide-binding groove interacting the N-terminus of bound peptides20, and 
in the α 2-1 helix of HLA-A*02:01 crystallized with different peptide and T-cell receptor combinations24. 
Further molecular dynamics simulations report how different peptides can influence the plasticity of the 
MHC I binding groove of HLA-B*27 alleles22,52, and recent NMR studies report conformational changes 
in T-cell receptor interaction of H2-Ld bound to different peptides45. Notably, polymorphisms at position 
156 in the α 2-1 helix in HLA-B*44 alleles, residing at a critical hinge-point important for articulating plas-
ticity have been linked to long-term non-progression in HIV-1 infected individuals41, and are associated 
with HLA-linked drug allergy40,53 and non-permissive transplantation mismatches42. These correlations 
between protein dynamics and disease pathogenesis are suggestive of the importance of MHC I plasticity 
throughout the MHC I antigen processing and presentation pathway. Therefore, whilst there remains 
much to be understood regarding precisely what determines the generation of immunogenic MHC I 
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molecules at the cell surface, the possibility of modulating protein plasticity as a therapeutic target pro-
vides an exciting avenue of investigation.
Methods
Molecular dynamics simulations. The GROMACS version 4.5.330 molecular dynamics package was 
used for the all atom simulations with the Amber99SB-ILDN54 force field. Further details are provided 
in the Supplementary Information. Specifically, we present block RMSF calculations in Figure S1 as our 
check for simulation stability, and also provide a summary of the statistics of the MD simulations in 
Table S1, including RMSD.
Cell lines. The 721.220 cell lines expressing tapasin, B*4402 and B*4405 are previously described10. 
RSV.5neo.B*44:05 was mutated at position 147 by site-directed mutagenesis. Mutation was confirmed 
by sequencing. 721.220 and 721.220.tapasin cells were transfected using Nucleofection and stable trans-
fectants were grown under G418 and/or puromycin selection. Phenotype was confirmed by FACS and 
Western blot analysis.
BFA Decay. For cell surface decay experiments, cells were treated with Brefeldin A for the specified 
time points. Cells were stained with W6/32 and analyzed by FACS. Surface MHC I was expressed as 
percentage of mean channel fluorescence at time point 0.
Pulse-chase and thermostability assays. These were carried out as previously described10 using 
10 μ Ci/ml 35S-Translabel and 500 U EndoH. Bands were detected using Personal Molecular Imager FX 
and quantified using Quantity One software.
Immunoprecipitations. Cells were lysed in PBS containing 1% Digitonin (WAKO), PMSF and IAA. 
Supernatants were pre-cleared with protein A sepharose, immunoprecipitated with anti-tapasin PaSta-1 
antibody (kind gift from Peter Cresswell) and complexes were recovered with protein A. Beads were 
washed in 0.1% Digitonin and eluted with Laemmli sample buffer. Eluted proteins and samples of lysate, 
prior to immunoprecipitation were separated by SDS-PAGE, transferred by Western blot and detected by 
chemilluminescence using Fluor-S Multimager. Anti-human TAP1, anti-HLA-B (N-20), HRP-conjugated, 
anti-rabbit light chain and anti-goat antibodies were used.
Computational modelling. The computational models were constructed as systems of chemical 
reactions, and simulated as ordinary differential equations assuming mass action kinetics. Numerical 
integration of the resulting equations and Bayesian parameter inference was performed as described 
previously27. Further details are provided in the Supplementary Information.
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